Literature DB >> 25127856

Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus.

Kristin Aas-Hanssen1, Ane Funderud2, Keith M Thompson2, Bjarne Bogen3, Ludvig A Munthe1.   

Abstract

Systemic lupus erythematosus (SLE) is marked by a Th cell-dependent B cell hyperresponsiveness, with frequent germinal center reactions and hypergammaglobulinemia. The specificity of Th cells in lupus remains unclear, but B cell Ids have been suggested. A hallmark is the presence of anti-dsDNA, mutated IgG autoantibodies with a preponderance of arginines in CDR3 of the Ig variable H chain (IgVH). B cells can present V region-derived Id peptides on their MHC class II molecules to Id-specific Th cells. We show that Id-specific Th cells support the proliferation of anti-dsDNA Id(+) B cells in mice suffering from systemic autoimmune disease with SLE-like features. Mice developed marked clonal expansions of B cells; half of the IgVH sequences were clonally related. Anti-dsDNA B cells made up 40% of B cells in end-stage disease. The B cells expressed mutated IgVH with multiple arginines in CDR3. Hence, Id-driven T cell-B cell collaboration supported the production of classical anti-dsDNA Abs, recapitulating the characteristics of such Abs in SLE. The results support the concept that Id-specific Th cells may trigger the development of SLE and suggest that manipulation of the Id-specific T cell repertoire could play a role in treatment.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25127856     DOI: 10.4049/jimmunol.1400640

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen.

Authors:  Rizwan Ahmed; Zahra Omidian; Adebola Giwa; Benjamin Cornwell; Neha Majety; David R Bell; Sangyun Lee; Hao Zhang; Aaron Michels; Stephen Desiderio; Scheherazade Sadegh-Nasseri; Hamid Rabb; Simon Gritsch; Mario L Suva; Patrick Cahan; Ruhong Zhou; Chunfa Jie; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

2.  Innate and humoral recognition of the products of cell death: differential antigenicity and immunogenicity in lupus.

Authors:  P Arora; M Malik; R Sachdeva; L Saxena; J Das; V G Ramachandran; R Pal
Journal:  Clin Exp Immunol       Date:  2016-12-05       Impact factor: 4.330

3.  CD4+ T Cells in the Blood of MS Patients Respond to Predicted Epitopes From B cell Receptors Found in Spinal Fluid.

Authors:  Rune A Høglund; Robert D Bremel; E Jane Homan; Silje Bøen Torsetnes; Andreas Lossius; Trygve Holmøy
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

Review 4.  Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides-As Antigens for Th Cells.

Authors:  Kristin Aas-Hanssen; Keith M Thompson; Bjarne Bogen; Ludvig A Munthe
Journal:  Front Immunol       Date:  2015-07-28       Impact factor: 7.561

Review 5.  T Cell Receptor Profiling in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Amanda Posgai; Howard R Seay; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2017-10-11       Impact factor: 4.810

6.  B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells.

Authors:  Peter Csaba Huszthy; Ramakrishna Prabhu Gopalakrishnan; Johanne Tracey Jacobsen; Ole Audun Werner Haabeth; Geir Åge Løset; Ranveig Braathen; Karl Schenck; Anders Aune Tveita; Ludvig Andre Munthe; Bjarne Bogen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-03       Impact factor: 11.205

Review 7.  Triggers of Autoimmunity: The Role of Bacterial Infections in the Extracellular Exposure of Lupus Nuclear Autoantigens.

Authors:  Connie C Qiu; Roberto Caricchio; Stefania Gallucci
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.